Novo Nordisk stock sinks after new trial data show weight-loss drug candidate CagriSema is less effective than a rival treatment from Eli Lilly.
These Stocks Are Today’s Movers: Novo Nordisk, Lilly, Arcellx, CrowdStrike, American Airlines, Strategy, Domino’s, and More
view original post